CompoSecure, Inc. today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”)

CompoSecure (NYSE: CMPO) announced that its stockholders approved the issuance of CompoSecure Class A common stock to effect a proposed business combination with Husky Technologies Limited.

Rhea-AI Summary

CompoSecure (NYSE: CMPO) announced that its stockholders approved the issuance of CompoSecure Class A common stock to effect a proposed business combination with Husky Technologies Limited.

The company said the transaction is expected to close in January 2026, subject to customary closing conditions and regulatory approvals. Final voting results will be reported in a Form 8-K filed with the SEC.

Argus Dec 24 session

+0.67% close to close Open Argus

Details

News Market Reaction – CMPO

On Dec 24, the day this news came out, CMPO closed 0.67% above the previous close.

Data tracked by StockTitan Argus for the Dec 24 session.

Key Figures

Cash consideration: $3.953 billion Stock consideration: 55,297,297 shares PIPE shares: 106,057,000 shares +5 more

Cash consideration

$3.953 billion

Husky combination deal consideration per PREM14A

Stock consideration

55,297,297 shares

CompoSecure common stock to Husky sellers per PREM14A

PIPE shares

106,057,000 shares

Private placement at $18.50 per share per PREM14A

PIPE price

$18.50 per share

Private placement pricing per PREM14A

PIPE proceeds

$1.96 billion

Expected gross proceeds from PIPE per PREM14A

First-lien term loan

$725 million

Debt commitment financing Husky transaction per PREM14A

Incremental term loan

$350 million

Additional term loan commitment per PREM14A

Ownership post-close

45% / 19% / 36%

Pro forma ownership CompoSecure / Sellers / PIPE investors per PREM14A

Historical Context

5 past events · Latest: Nov 03

5 events

1. Nov 03

   Earnings & merger

   24h Move

   +3.4%

   Strong 3Q25 metrics and announcement of Husky combination with raised guidance.

2. Oct 27

   Earnings call setup

   24h Move

   +2.1%

   Scheduling Q3 2025 results conference call and webcast details.

3. Oct 09

   Management change

   24h Move

   -3.7%

   Appointment of new CFO with retirement of prior CFO and transition support.

4. Sep 24

   Strategic partnership

   24h Move

   -1.5%

   Arculus partnership with N.exchange to add crypto swaps and smart order routing.

5. Sep 08

   Listing transfer

   24h Move

   -2.5%

   Transfer of Class A share listing from Nasdaq to NYSE while keeping ticker.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

business combination, class a common stock, regulatory approvals, form 8-k, +1 more

5 terms

business combination financial

"in connection with the proposed business combination with Husky Technologies Limited"

A business combination happens when two or more companies join together to operate as one, like two friends merging their teams into a single group. This is important because it can change how companies grow, compete, and make money, often making them bigger and more powerful in the market.

class a common stock financial

"approved the issuance of shares of CompoSecure Class A Common Stock in connection"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

regulatory approvals regulatory

"subject to customary closing conditions, including regulatory approvals."

Regulatory approvals are official permissions from government agencies that a company needs before launching a new product, service, or business activity. They matter because without this approval, the company might not be allowed to operate legally or sell its products, similar to how a driver needs a license to legally drive a car.

form 8-k regulatory

"results ... will be set forth in a Form 8-K filed by CompoSecure"

A Form 8-K is a report that companies file with the government to share important news quickly, such as changes in leadership, major business deals, or financial updates. It matters because it helps investors stay informed about significant events that could affect the company's value or stock price.

securities and exchange commission regulatory

"filed by CompoSecure with the U.S. Securities and Exchange Commission"

A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SOMERSET, N.J., Dec. 24, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (NYSE: CMPO) today announced that its stockholders have approved the issuance of shares of CompoSecure Class A Common Stock in connection with the proposed business combination with Husky Technologies Limited (“Husky”). The business combination with Husky is expected to close in January 2026, subject to customary closing conditions, including regulatory approvals. 

The final voting results from CompoSecure’s special meeting of stockholders will be set forth in a Form 8-K filed by CompoSecure with the U.S. Securities and Exchange Commission (the “SEC”).

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the federal securities laws. Statements that are not historical facts, including statements about demand letters and complaints relating to the transactions, the timing and completion of the transactions, expected benefits, future plans, expectations and opportunities, are forward-looking statements. Forward-looking statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially. Important factors include, among others: (i) the risk that the transactions may not be completed in a timely manner or at all; (ii) the failure to obtain required approvals, including regulatory approvals; (iii) the occurrence of any event that could give rise to termination of the Share Purchase Agreement; (iv) the effect of the announcement, pendency or consummation of the transactions on the parties’ business relationships, operations, financial and accounting matters; (v) risks that the expected benefits of the transactions, including financial projections, estimates and outlook, may not be fully realized or may take longer to realize than expected; (vi) risks related to financing the transactions; (vii) costs related to the transactions; (viii) potential litigation and/or regulatory actions relating to the transactions, including the demand letters and complaints described herein, and otherwise; (ix) general economic, market, industry and competitive conditions; and (x) other risks and uncertainties described in CompoSecure’s filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent Quarterly Reports on Form 10-Q, which identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Forward-looking statements speak only as of the date made. CompoSecure undertakes no obligation to update any forward-looking statements, except as required by law.

CompoSecure Investor Relations Contact
Sean Mansouri, CFA
Elevate IR
(720) 330-2829
CMPO@elevate-ir.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did CompoSecure (CMPO) stockholders approve on December 24, 2025?

Stockholders approved the issuance of CompoSecure Class A common stock in connection with the proposed business combination with Husky.

When is the CompoSecure and Husky business combination expected to close?

The companies expect the business combination to close in January 2026, subject to customary closing conditions and regulatory approvals.

Does the CompoSecure announcement mention regulatory approval for the CMPO–Husky deal?

Yes. The closing is subject to customary closing conditions, including regulatory approvals.

Where will CompoSecure (CMPO) publish the final special meeting voting results?

CompoSecure said final voting results will be set forth in a Form 8-K filed with the U.S. Securities and Exchange Commission.

Will the approved share issuance for CMPO immediately change the stock count?

The announcement states stockholders approved the issuance tied to the proposed combination, but it says the transaction closes in January 2026 and is subject to closing conditions before shares are issued.